Profund Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.6M | Buy |
23,398
+261
| +1% | +$116K | 0.32% | 42 |
|
|
2026
Q1 | $10.3M | Sell |
23,137
-5,681
| -20% | -$2.65M | 0.38% | 37 |
|
|
2025
Q4 | $13.1M | Buy |
28,818
+2,423
| +9% | +$1.04M | 0.4% | 36 |
|
|
2025
Q3 | $10.3M | Sell |
26,395
-958
| -4% | -$400K | 0.34% | 49 |
|
|
2025
Q2 | $12.2M | Buy |
27,353
+2,682
| +11% | +$1.24M | 0.44% | 37 |
|
|
2025
Q1 | $12M | Sell |
24,671
-3,903
| -14% | -$1.82M | 0.52% | 34 |
|
|
2024
Q4 | $11.5M | Buy |
28,574
+654
| +2% | +$303K | 0.42% | 38 |
|
|
2024
Q3 | $13M | Sell |
27,920
-1,626
| -6% | -$781K | 0.49% | 32 |
|
|
2024
Q2 | $13.8M | Buy |
29,546
+3,194
| +12% | +$1.39M | 0.51% | 31 |
|
|
2024
Q1 | $11M | Sell |
26,352
-1,730
| -6% | -$731K | 0.43% | 36 |
|
|
2023
Q4 | $11.4M | Buy |
28,082
+3,495
| +14% | +$1.29M | 0.49% | 33 |
|
|
2023
Q3 | $8.55M | Buy |
24,587
+4,653
| +23% | +$1.63M | 0.47% | 34 |
|
|
2023
Q2 | $7.01M | Buy |
19,934
+967
| +5% | +$326K | 0.38% | 39 |
|
|
2023
Q1 | $5.98M | Sell |
18,967
-22,299
| -54% | -$6.69M | 0.37% | 42 |
|
|
2022
Q4 | $11.9M | Sell |
41,266
-18
| -0% | -$5.49K | 0.77% | 21 |
|
|
2022
Q3 | $12M | Sell |
41,284
-2,018
| -5% | -$581K | 0.86% | 19 |
|
|
2022
Q2 | $12.2M | Sell |
43,302
-5,796
| -12% | -$1.55M | 0.77% | 23 |
|
|
2022
Q1 | $12.8M | Sell |
49,098
-9,510
| -16% | -$2.26M | 0.54% | 30 |
|
|
2021
Q4 | $12.9M | Sell |
58,608
-8,612
| -13% | -$1.67M | 0.42% | 41 |
|
|
2021
Q3 | $12.2M | Buy |
67,220
+37
| +0.1% | +$7.22K | 0.41% | 39 |
|
|
2021
Q2 | $13.5M | Sell |
67,183
-2,206
| -3% | -$461K | 0.46% | 39 |
|
|
2021
Q1 | $14.9M | Sell |
69,389
-1,990
| -3% | -$437K | 0.57% | 26 |
|
|
2020
Q4 | $16.9M | Buy |
71,379
+5,230
| +8% | +$1.2M | 0.74% | 21 |
|
|
2020
Q3 | $18M | Sell |
66,149
-8,501
| -11% | -$2.35M | 0.93% | 17 |
|
|
2020
Q2 | $21.7M | Buy |
74,650
+9,783
| +15% | +$2.65M | 1.21% | 15 |
|
|
2020
Q1 | $15.4M | Sell |
64,867
-21,092
| -25% | -$4.84M | 1.16% | 14 |
|
|
2019
Q4 | $18.8M | Buy |
85,959
+8,698
| +11% | +$1.76M | 0.82% | 19 |
|
|
2019
Q3 | $13.1M | Sell |
77,261
-4,059
| -5% | -$718K | 0.66% | 22 |
|
|
2019
Q2 | $14.9M | Sell |
81,320
-6,390
| -7% | -$1.12M | 0.71% | 18 |
|
|
2019
Q1 | $16.1M | Buy |
87,710
+1,342
| +2% | +$248K | 0.78% | 17 |
|
|
2018
Q4 | $14.3M | Sell |
86,368
-20,840
| -19% | -$3.61M | 0.89% | 18 |
|
|
2018
Q3 | $20.7M | Buy |
107,208
+9,424
| +10% | +$1.68M | 0.78% | 18 |
|
|
2018
Q2 | $16.6M | Sell |
97,784
-4,648
| -5% | -$720K | 0.66% | 22 |
|
|
2018
Q1 | $16.7M | Sell |
102,432
-7,484
| -7% | -$1.22M | 0.66% | 25 |
|
|
2017
Q4 | $16.5M | Sell |
109,916
-11,097
| -9% | -$1.64M | 0.64% | 24 |
|
|
2017
Q3 | $18.4M | Buy |
121,013
+9,680
| +9% | +$1.46M | 0.77% | 20 |
|
|
2017
Q2 | $14.3M | Sell |
111,333
-6,177
| -5% | -$744K | 0.65% | 21 |
|
|
2017
Q1 | $12.8M | Sell |
117,510
-7,989
| -6% | -$703K | 0.57% | 26 |
|
|
2016
Q4 | $9.25M | Sell |
125,499
-16,592
| -12% | -$1.35M | 0.43% | 35 |
|
|
2016
Q3 | $12.4M | Sell |
142,091
-5,790
| -4% | -$547K | 0.59% | 26 |
|
|
2016
Q2 | $12.7M | Sell |
147,881
-6,508
| -4% | -$562K | 0.62% | 21 |
|
|
2016
Q1 | $12.3M | Sell |
154,389
-34,724
| -18% | -$3.14M | 0.64% | 23 |
|
|
2015
Q4 | $23.8M | Buy |
189,113
+1,006
| +0.5% | +$121K | 1.13% | 14 |
|
|
2015
Q3 | $19.6M | Sell |
188,107
-10,171
| -5% | -$1.31M | 1.12% | 14 |
|
|
2015
Q2 | $24.5M | Sell |
198,278
-891
| -0.4% | -$112K | 1.01% | 15 |
|
|
2015
Q1 | $23.5M | Buy |
199,169
+12,336
| +7% | +$1.48M | 0.91% | 15 |
|
|
2014
Q4 | $22.2M | Buy |
186,833
+18,707
| +11% | +$2.11M | 0.91% | 14 |
|
|
2014
Q3 | $18.9M | Buy |
168,126
+13,893
| +9% | +$1.32M | 0.88% | 16 |
|
|
2014
Q2 | $14.6M | Sell |
154,233
-38,354
| -20% | -$2.69M | 0.64% | 21 |
|
|
2014
Q1 | $13.6M | Buy |
192,587
+34,251
| +22% | +$2.71M | 0.62% | 21 |
|
|
2013
Q4 | $11.8M | Buy |
158,336
+31,950
| +25% | +$2.22M | 0.53% | 18 |
|
|
2013
Q3 | $9.58M | Sell |
126,386
-8,093
| -6% | -$644K | 0.51% | 20 |
|
|
2013
Q2 | $10.7M | Buy |
+134,479
| New | +$9.9M | 0.76% | 16 |
|
Other funds holding VRTX
Profund Advisors's VRTX Position: Q2 2026 in Review
Profund Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 1.1% in Q2 2026, buying an estimated $116K and bringing the position to 23,398 shares worth $11.6M. The position accounts for 0.32% of the portfolio, ranked #42.
Profund Advisors first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $24.5M in Q2 2015. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Profund Advisors held 23,398 shares of Vertex Pharmaceuticals worth $11.6M as of Q2 2026.
- Profund Advisors bought 261 Vertex Pharmaceuticals shares in Q2 2026, an estimated $116K.
- Vertex Pharmaceuticals made up 0.32% of Profund Advisors's portfolio in Q2 2026, its #42 holding.
- Profund Advisors first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Profund Advisors's Vertex Pharmaceuticals position peaked at $24.5M in Q2 2015.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.